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Abstract
The latency-associated nuclear antigen (LANA-1) of Human Herpes Virus 8 (HHV-8), alternatively
called Kaposi Sarcoma Herpes Virus (KSHV) is constitutively expressed in all HHV-8 infected cells.
LANA-1 accumulates in well-defined foci that co-localize with the viral episomes. We have
previously shown that these foci are tightly associated with the borders of heterochromatin [1].
We have also shown that exogenously expressed LANA-1 causes an extensive re-organization of
Hoechst 33248 DNA staining patterns of the nuclei in non-HHV-8 infected cells [2]. Here we show
that this effect includes the release of the bulk of DNA from heterochromatic areas, in both human
and mouse cells, without affecting the overall levels of heterochromatin associated histone H3
lysine 9 tri-methylation (3MK9H3). The release of DNA from the heterochromatic chromocenters
in LANA-1 transfected mouse cells co-incides with the dispersion of the chromocenter associated
methylcytosin binding protein 2 (MECP2). The localization of 3MK9H3 to the remnants of the
chromocenters remains unaltered. Moreover, exogeneously expressed LANA-1 leads to the
relocation of the chromocenters to the nuclear periphery, indicating extensive changes in the
positioning of the chromosomal domains in the LANA-1 harboring interphase nucleus. Using a
series of deletion mutants we have shown that the chromatin rearranging effects of LANA-1
require the presence of a short (57 amino acid) region that is located immediately upstream of the
internal acidic repeats. This sequence lies within the previously mapped binding site to histone
methyltransferase SUV39H1. We suggest that the highly concentrated LANA-1, anchored to the
host genome in the nuclear foci of latently infected cells and replicated through each cell
generation, may function as "epigenetic modifier". The induction of histone modification in adjacent
host genes may lead to altered gene expression, thereby contributing to the viral oncogenesis.
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Human herpesvirus virus 8 (HHV-8) is considered as the
causative agent of Kaposi's sarcoma (KS) and is also asso-
ciated with primary effusion lymphomas (PELs) and mul-
ticentric Castleman's disease (MCD). It is a
gammaherpesvirus that shows sequence homology to
Epstein-Barr virus (EBV) and herpesvirus saimiri (HVS)
that are able to transform B (EBV) and T cells (HVS),
respectively. Both viruses can cause malignant lympho-
mas [3]. HHV-8 encodes a large number of proteins that
show structural similarities with cellular proteins involved
in cellular proliferation, cell cycle regulation and immune
modulation [4]. A human cyclin D homologue, vCYC,
ORF72, a bcl-2 homologue, ORF16 [5], an IL-8-like G-
protein coupled receptor, vGCRP, ORF74 [6] and inter-
feron regulatory factors, vIRFs, ORFK9, ORFK10.5 [4] are
among the genes that have been pirated by the virus.
The latency-associated nuclear antigen (LANA-1, LNA or
LNA-1), encoded by ORF73, is one of few HHV-8 encoded
proteins that is highly expressed in all latently infected
tumor cells [7-9]. This suggests that LANA-1 plays a critical
role in maintenance of latent HHV-8 infection. LANA-1 is
a 222–234 kDa phosphoprotein with an acidic internal
repeat domain flanked by a carboxy-terminal domain and
an amino-terminal domain [9].
Constitutive expression of LANA-1 from its own promoter
in transgenic mice induced splenic follicular hyperplasia
due to an expansion of IgM+ IgD+ B cells and led to
increased germinal center formation. LANA-1 expressing
B-cell lesions could also progress to lymphomas [10].
LANA-1 acts as a transcriptional regulator. It has been
shown to bind to p53 and to the retinoblastoma protein
pRb. This leads to the inactivation of p53-dependent pro-
moters and induction of E2F-dependent genes [11,12].
Together with the cellular oncogene H-ras, LANA-1 trans-
forms primary rat embryo fibroblasts [13]. It can transac-
tivate the promoter of the reverse transcriptase subunit of
the human telomerase holoenzyme [14]. Activation of tel-
omerase is a critical step in cellular transformation [15].
LANA-1 is also involved in transcriptional repression,
however [16-18]. It can, moreover, interact with the
mSin3/HDAC1 co-repressor complex [17]. It has been
also shown to interact with and inhibit the ATF4/CREB2
transcription factor that interacts with the basic transcrip-
tion machinery [19]. LANA-1 was also reported to bind
two human chromosome-associated cellular proteins,
MeCP2 and DEK [17].
RING3, a homology of the fsh (female sterile homeotic)
gene product of Drosophila, interacts with LANA-1 [20].
This results in the phosphorylation of LANA-1. We have
shown by immunofluorescence that LANA-1 can re-locate
RING3 into heterochromatin regions and that LANA-1
and RING3 co-localize in the nuclear bodies of BCBL-1
cells. Exogenously expressed LANA-1 increased the expres-
sion of RING3 [2].
LANA-1 is associates with cellular chromatin and stays on
the chromosomes during cell division [21]. It maintains
the viral genomes during cell division by tethering the
viral episomes to the chromosomes [22]. It binds directly
to replication origin recognition complexes (ORCs) that
are primarily associated with the terminal repeat (TR)
region of the HHV-8 genome [23]. Binding of LANA-1 to
TR confers transcriptional silencing, on the promoter of
the neighbouring lytic gene K1 [24]. LANA-1 is believed to
play an important role in the suppression of lytic viral
genes and maintenance of viral latency. The key lytic reg-
ulator protein, RTA activates the expression of several lytic
viral genes by interacting with recombination signal
sequence-binding protein Jkappa (RBP-Jkappa), a tran-
scriptional repressor and the target of the Notch signaling
pathway. Importantly, LANA-1 also suppresses RTA activ-
ity by its direct binding to RBP-Jkappa [25].
Distinct regions of the N-terminus of LANA-1 are respon-
sible for nuclear targeting and binding to human chromo-
somes [26]. The 1–22 N terminal residues of LANA-1 bind
directly to an acidic patch on the core histone dimers
H2A-H2B [27]. LANA-1 shows a characteristic cellular dis-
tribution. The HHV-8 episomes and the associated LANA-
1 protein accumulate in irregularly shaped bodies in the
interphase nucleus, preferentially at the border of hetero-
chromatin [1]. It binds to human metaphase chromo-
somes in an apparently random fashion [21,26].
Exogeneously expressed C terminal part of LANA-1 prefer-
entially concentrates to paired dots at pericentromeric and
peri-telomeric regions of a subset of mitotic chromo-
somes [28]. A short 15 aa region in the C terminal part is
responsible for the association with heterochromatin
[29]. This chromatin-binding domain is required for mul-
tiple LANA-1 functions, such as the ability to bind to and
replicate viral episomes, to modulate transcription, and to
interact with the members of Brd chromatin binding pro-
teins Brd2/RING3 and Brd4s [30-32].
We have previously shown that exogenous expression of
LANA-1 induces a major re-organization of DNA staining
patterns. Here we show that this reorganization leads to
the disappearance of normal heterochromatin pattern in
both human and mouse cells. In order to further charac-
terize the effect of LANA-1 on heterochromatin we have
compared its distribution in HHV-8 carrying cells and in
non-infected but LANA-1 transfected cells in relation to
different heterochromatin markers.Page 2 of 16
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Cell culture conditions and cell lines
The cells were cultured at 37°C at 5% CO2 in Iscove's
modified Dulbecco's cell culture medium supplemented
with 10% heat-inactivated fetal bovine serum (FBS), 100
U/ml penicillin and 100 U/ml streptomycin. The cells
were passaged and split 1:5 every fourth day. The cell cul-
tures were regularly tested for the absence of mycoplasma
infection by Hoechst 33258 staining. The cell lines used in
this study were the following: the HHV-8 infected human
body cavity lymphomas BC-1 and BCBL-1; human breast
carcinoma MCF-7; human osteosarcoma cell line Saos-2,
human cervical carcinoma HeLa; immortalized mouse
fibroblasts NIH3T3 and mouse fibrosarcoma L (American
Type Culture Collection (ATCC).
Transient transfection procedure
The human or mouse cells were grown on coverslips in
six-well plates and transfected for 24–48 hours using a
full-length LANA-1 cDNA inserted into a pcDNA1 vector
or a LANA-1 deletion constructs [29]. An empty vector or
a pBabe EBNA-5 construct created by us was used for con-
trol transfections. Transfection of cells was made accord-
ing to the manufacturer's instructions using FuGene6
(Roche).
Immunofluorescence microscopy
The transfected cells (grown on coverslips) or body cavity
lymphoma cell lines (cytospinned on to glass slides) were
fixed in methanol: acetone (1:1) at -20°C for 20 min. The
re-hydration of cells was done in PBS for 20 min at room
temperature. The following antibodies were used in this
study for immunofluorescence straining: human anti-
LANA KS2 (antiserum, a gift from Attila Juhasz, the Der-
matology Unit of Debrecen Medical School, Hungary),
rabbit polyclonal anti-tri-methyl K9 histone H3 (A gift
from Dr Prim Sing); rabbit polyclonal IgG anti-mouse
MeCP2 (reacting with both human and murin MeCP2)
(Upstate); FITC-conjugated swine anti-rabbit (DAKO);
rhodamine-conjugated rabbit anti-human (DAKO); FITC-
conjugated rabbit anti-human (DAKO) or Texas red-con-
jugated horse anti-mouse (Vector) were used as secondary
antibodies. The different combinations of primary and
secondary antibodies are specified in respective figures.
The control transfection of pBabe-EBNA-5 was stained
with a mouse monoclonal anti-EBNA-5 (JF186)[33].
Texas red-conjugated horse anti-mouse (Vector) was used
as secondary antibody. The antibodies were diluted in
blocking buffer (2% BSA, 0.2% Tween-20, 10% glycerol,
0.05% NaN3 in PBS). The primary antibodies were incu-
bated in a humid chamber at room temperature for one
Comparison of expression levels of virus encoded and exogeneously introduced LANA-1 in the nucleus of HHV-8 positive BCBL-1 b dy cavity lymphoma (left) and HHV-8 negative MCF7 breast carcinoma cell (middle)Figure 1
Comparison of expression levels of virus encoded and exogeneously introduced LANA-1 in the nucleus of HHV-8 positive 
BCBL-1 body cavity lymphoma (left) and HHV-8 negative MCF7 breast carcinoma cell (middle). Immunofluorescence staining 
(green) using human anti-LANA-1 serum detected by FITC conjugated mouse anti-human immunoglobulins. The images are Z 
axis projections of stacks of 10 optical sections, 0.5 micrometer apart, captured from identically stained and processed nuclei 
using an automated wide field fluorescence microscope. The counterstaining of BCBL-1 DNA with Hoechst 33258 (blue) is 
shown for easier orientation. The 3D projection of the plot of the measured staining intensity (right) illustrates that the nuclear 
foci of latently infected cells contain comparable amount of LANA-1 to the transiently transfected ones.Page 3 of 16
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the secondary antibodies was done for one hour in humid
chamber at room temperature. Double staining between
LANA-1 and the different chromatin-associated proteins
were done as follows: rabbit anti-tri-methyl K9 H3 or rab-
bit anti-MeCP2, FITC-conjugated swine anti-rabbit, nor-
mal rabbit, human anti LANA-1 and at last rhodamine
conjugated rabbit anti-human. DEK double staining:
mouse anti-DEK, Texas red conjugated horse anti-mouse,
normal mouse, human anti-LANA1 and FITC conjugated
rabbit anti-human. The DNA was stained with Hoechst
33258. Each incubation step was followed by three
washes in PBS.
The images were captured with one of the following sys-
tems: Leitz DM RB wide field fluorescence microscope
equipped with a Hamamatsu dual mode cooled CCD
camera C4880 where the images were recorded and ana-
lysed on a Pentium PC computer equipped with an AFG
VISIONplus-AT frame grabber board using Hipic 4.0.4
(Hamamatsu), Image-Pro Plus (Media Cybergenetics).
Digital images were assembled using Adobe PHO-
TOSHOP software. Alternatively a Zeiss Axiophot micro-
scope was used to reconstitute images from a series of
optical sections that were de-blurred by removing the out-
of-focus blur using a nearest neighbor de-convolution
algorithm developed by us. On this system the images
were captured with a PXL cooled camera (Photometrics,
Munich, Germany) and analyzed using our own image
capture and analysis programs developed on ISee graphi-
cal programming language running under Mandrake
LINUX OS on a Pentium PC computer [34]. Confocal
images and very large field mosaics were captured using
our custom built dual mode Ultraview (combined RS and
LCI) system (Perkin Elmer) using imaging automations
QuantCapture 4.0 and QuantCount 3 that we have devel-
oped using OpenLab Automator programming environ-
ment (Improvision). 3D reconstitution was carried out
using Volocity (Improvision) or ImageJ programs.
Results
Effect of exogeneously expressed LANA-1 on nuclear 
structures of human cells
HHV-8 infected cells harbor LANA-1 in a spatially strictly
restricted manner. The majority of LANA-1 is associated
with well-defined nuclear areas that also contain viral epi-
somes (here referred as LANA bodies). Although there are
multiple binding sites in the viral terminal repeat, we have
estimated that the amount of LANA-1 concentrated in the
nuclear foci is orders of magnitude higher than the one
that can form direct contact with the viral DNA. In order
to model the effect of high LANA-1 concentration on the
organization of chromatin in the neighborhood of LANA
bodies, we overexpressed LANA-1 in transiently trans-
fected MCF7, HeLA or Saos-2 cells. The level of expression
was determined by measuring the fluorescence signal
intensities on identically processed, immunostained
slides, using manual, semi-automated or fully automated
wide-field or spinning disc confocal fluorescence micros-
copy. The measurement data demonstrated that the focal
expression levels of LANA-1 in the LANA bodies were
comparable to the levels reached in the transiently trans-
fected cells (Figure 1). Expression of LANA-1 in compara-
ble quantities that occur in the LANA bodies has led to
profound rearrangement of nuclear structures in the tran-
siently transfected cells. In human cells this is most prom-
inently demonstrated by the effect on perinucleolar
heterochromatin. Two major, distinct type of chromatin
alterations were observable. In a fraction of transfected
cells LANA-1 overexpression led to the almost homogene-
ous elimination of chromatin staining pattern (Figure 2
middle panel) whereas in other cells a novel condensed
chromatin pattern appeared, that was somewhat similar
to the morphology of premature chromosome condensa-
tion observable in mitosis/interphase cell hybrids (Figure
2 bottom panel). Importantly both type of chromatin
change had a major effect on the heterochromatin.
LANA-1 (green) dissolves DNA (blue) from perinucleolar heterochromatin in transfected MCF7 cellsFigure 2
LANA-1 (green) dissolves DNA (blue) from perinucleolar 
heterochromatin in transfected MCF7 cells. Increasing 
amount of transfected LANA-1 (compare top to the middle 
or bottom panels) leads to the elimination of the DNA stain-
ing (blue) in the perinucleolar heterochromatic rings. Adja-
cent non-transfected cells serve as controls. Right panel 
shows magnified pictures of chromatin organization of the 
selected nuclear areas selected by red border boxes in the 
left panel. The middle and bottom panels represent the two 
distinct types of chromatin effects: The smoothing out of the 
chromatin staining (middle panel) versus induction of newly 
condensed chromatin cords (bottom panel). Importantly 
both changes lead to the elimination of perinucleolar hetero-
chromatin.Page 4 of 16
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Dissolution of DNA from perinucleolar heterochromatin is not accompanied by the release of trimethylated lysine 9 histone H3 (3MK9H3) – green i munofluorescence staining in LANA-1 transfected cells (r d)Figure 3
Dissolution of DNA from perinucleolar heterochromatin is not accompanied by the release of trimethylated lysine 9 histone 
H3 (3MK9H3) – green immunofluorescence staining in LANA-1 transfected cells (red). 3MK9H3 staining clearly identifies peri-
nucleolar areas (white arrows) with diminished heterochromatic DNA staining in the transfected cells.
Molecular Cancer 2007, 6:28 http://www.molecular-cancer.com/content/6/1/28Increasing levels of LANA-1 led to the disappearance of
heterochromatin from the perinucleolar areas as defined
by Hoechst 33258 staining (compare the top panel of Fig-
ure 2 to the middle or bottom panel). Importantly this
effect was not associated by a similar release of the hetero-
chromatin marker trimethylated lysine 9 on histone H3
(3MK9H3) from the perinucleolar areas. On the contrary
3MK9H3 positive heterochromatin remnants appeared to
be collapsed into smaller spherical structures (Figure 3).
Measuring the amount of 3MK9H3 in the nuclei of MCF7
cells, 48 hours after transfection, using automated
Extended Field Laser Confocal Microscopy (EFLCM), we
found no significant difference between the total amount
LANA-1 expression does not effect 3MK9H3 (green) levels as measured using extended field laser scanning microscopy (EFLCM) that aut matically captured 300 adjacent fields as a mosaic of Z projected images of 12 optical sections ea hFigure 4
LANA-1 expression does not effect 3MK9H3 (green) levels as measured using extended field laser scanning microscopy 
(EFLCM) that automatically captured 300 adjacent fields as a mosaic of Z projected images of 12 optical sections each. The 
total fluorescence intensity measurement for 3MK9H3, DNA (blue) and LANA-1 (red) of the individual nuclei is plotted in the 
order of increasing amount of LANA-1. The amount of 3MK9H3 staining is also compared on population levels of LANA-1 
positive and negative nuclei on a box chart.Page 6 of 16
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cells (Figure 4).
Effect of exogenously expressed LANA-1 on nuclear 
structures of mouse cells
Morphological analysis of heterochromatic structures is
cumbersome in human cells because of the rather diffuse
border between the euchromatin and heterochromatin
areas. The discrimination between the two types of chro-
matin is much easier in mouse cells where the pericentro-
meric alfa-satellite repeats are organized in very well
defined heterochromatic chromocenters. We have previ-
ously shown that LANA-1 has retained its ability to target
mouse heterochromatin in BCBL-1/Sp2 human/mouse
synkaryon hybrids [1]. In order to test the effect of LANA-
1 on mouse chromocenters we have transfected A9 and L
cells as well as NIH3T3 fibroblasts with LANA-1. All tree
lines showed the same effect. Increasing amount of LANA-
1 has led to the disappearance of chromocenters by
Hoechst 33258 staining and formation of condensed
chromatin at the nuclear periphery or in the perinucleolar
areas (Figure 5). Interestingly the disappearance of the
bulk of the DNA from the chromocenters, as illustrated on
single narrow confocal sections of transfected and control
nuclei (Figure 6) was not followed by the disappearance
of 3MK9H3 staining (Figure 6). As in human cells, LANA-
1 transfected mouse cells contained similar amounts of
3MK9H3 as non-transfected cells and both the number
and the staining intensity of individual 3MK9H3 foci was
unaltered. Importantly, however, the localization of
3MK9H3 foci was dramatically changed (Figure 7).
Whereas in the untransfected cells the 3MK9H3 foci were
evenly distributed throughout the entire nucleus, they
were almost exclusively localized to the nuclear periphery
in the transfected cells (Figure 8). High resolution optical
sectioning and 3D reconstitution of the confocal image
series showed that the relocation of the foci was an early
event that has preceded the release of Hoechst stained
chromatin from the chromocenters (Figure 9) [see Addi-
tional files 1 and 2]. The release of Hoechst stained DNA
from the chromocenters was accompanied with a major
rearrangement in the staining pattern of an other hetero-
chromatin binding factor, the methyl cytosine binding
protein 2 (MECP2) in mouse L-cells. Increasing expres-
sion of LANA-1 led to the gradual dissolution of MECP2
foci that were stringently associated with the chromocent-
ers in untransfected cells. In transfected cells, MECP2 was
released from the foci and appeared in the areas of the
newly formed condensed chromatin bundles but showed
no co-localization with LANA-1 itself (Figure 10). This
lack of co-localization was also consistent with the
absence of co-localization between LANA-1 and MECP2
in HHV-8 carrying BCBL-1 cells (Figure 11).
Mapping the LANA-1 region required for the chromatin 
effects using deletion mutants
We have tested a series of C-terminal deletion mutants
that did or did not contain the central acidic repeat
Effect of LANA-1 on mouse pericentromeric heterochromatin organized as chromocentersFigure 5
Effect of LANA-1 on mouse pericentromeric heterochromatin organized as chromocenters. Increasing amount of LANA-1 
(green) leads to gradual disappearance of chromocenters in the transfected nuclei of murine L-cells. DNA stained with 
Hoechst 33258 (blue).Page 7 of 16
(page number not for citation purposes)
Molecular Cancer 2007, 6:28 http://www.molecular-cancer.com/content/6/1/28
Page 8 of 16
(page number not for citation purposes)
High resolution comparison of LANA-1 (red) positive L-cell nucleus with an adjacent non-transfected cell in a single optical section that slices both nuclei in the middl  levelFi ur  6
High resolution comparison of LANA-1 (red) positive L-cell nucleus with an adjacent non-transfected cell in a single optical 
section that slices both nuclei in the middle level. The intensity plot is recorded along the white line and demonstrate a massive 
release of the bulk DNA (blue) from the chromocenters in the transfected cell without effecting the 3MK9H3 (green) levels in 
the remnants of the chromocenters (white staple on the right side of the line plot).
Molecular Cancer 2007, 6:28 http://www.molecular-cancer.com/content/6/1/28regions for their effect on the chromatin organization in
human and mouse cells. The C terminal truncation had
no effect on LANA-1 induced chromatin rearrangement,
while deletions of the central acidic repeat eliminated this
effect (summarized in Figure 12). Deletion mutants lack-
ing the central repeats (delta mutants) retained the capac-
ity to target the surface of heterochromatin both in
human and mouse cells, but had no effect on the organi-
zation of chromatin itself (Figure 13). To identify the
region that was involved in the chromatin reorganizing of
LANA-1 more precisely, we tested mutants that retained
the immediate neighboring sequences of the central
repeats. We found that a mutant (del 332–972) that
lacked the internal repeats but retained the immediate
upstream region that precedes the DE repeats was active in
rearranging the chromatin (Figure 14). The compiled data
showed that this 57 amino acids long region (aa. 275–
332) was required for the chromatin effects. Importantly
this area is overlapping with the previously mapped bind-
ing site for the histone methyl transferase SUV39H1 [35].
Discussion
HHV8 carrying cells can harbor up to a few dozen viral
episomes that localize in discrete nuclear compartments
delineated by LANA-1. LANA-1 as multifunctional virally
encoded protein, involved in the maintenance of the viral
episomes, regulation of viral latency, transcriptional regu-
lation of viral and cellular genes and impairment of cell
cycle checkpoints [36]. Several of these functions may
play a role in the HHV8 induced malignant transforma-
tion of Kaposi sarcoma and body cavity lymphoma cells.
In this paper we have presented additional evidence that
LANA-1 may also have fundamental effects on the organ-
ization of the interphase nucleus. They are most clearly
seen in mouse cell nuclei where the pericentromeric hete-
rochromatin forms easily recognizable chromocenters.
The bulk of the heterochromatin associated DNA is
released from the chromocenters without affecting their
3MK9H3 content. This suggests indirectly, that a large part
of the DNA that is associated with the chromocenters con-
tains nucleosomes that are not trimethylated on the 9th
lysine of histone H3, a modification that is considered to
be the hallmark of heterochromatin organization. Our
data suggest that chromatin with 3MK9H3 modified
Although single optical sections (left) of LANA-1-transfected nuclei may suggest extensive decrease in 3MK9H3 staining, reconstitution of the summarized staining signal from th  entire stack of 15 images (right) shows no detectable alteration in the to al level  f 3MK9H3 in m use L cell nucleiFigur  7
Although single optical sections (left) of LANA-1-transfected nuclei may suggest extensive decrease in 3MK9H3 staining, 
reconstitution of the summarized staining signal from the entire stack of 15 images (right) shows no detectable alteration in the 
total levels of 3MK9H3 in mouse L cell nuclei. (LANA-1 – red, 3MK9H3 – green, DNA – blue).Page 9 of 16
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somes inside the heterochromatic areas and that LANA-1
has a strong dispersing effect on this type of chromatin. It
is likely that this chromatin fraction is heavily methylated
on CpG sites, indicated by the profound effect on the dis-
tribution of MECP2 protein. The release of MECP2 from
heterochromatin is probably not due to a direct stable
interaction with LANA-1 because the two proteins showed
no co-localization in either the transfected or in the virus
carrying cells. LANA-1 binds MECP2 in vitro and in co-
immunoprecipitation experiments. The presented mor-
phological distribution data suggest that this interaction
in vivo may occur outside of the LANA bodies in the virus
infected cells and the complex may have a short half life.
3MK9H3 labelled chromocenter remnants may also func-
tion as markers of the centromeric side of interphase chro-
mosome domains in mouse cells. The relocation of these
foci from the interior of the nucleus to the nuclear periph-
ery indicates major reshuffling of individual chromo-
somes in the LANA-1 containing interphase nuclei. The
mechanism that determines the position of the different
chromosomal domains in the nucleus is debated. Several
theories were proposed to explain the relative localization
and movements of chromosomal domains within the
interphase nucleus. They can be referred to as the gene
density theory, chromosome size theory and the mitotic
pre-set theory (position within the metaphase plate), as
reviewed by [37,38]. The relative position and mobility of
individual chromosomes have an obvious bearing on the
occurence of chromosomal translocations. Our findings
Careful examination of the series of sixteen individual optical sections along the Z axis reveals that LANA-1 induces a major rearrangement in the positioning of 3MK9H3 pos tive chromoc nter rem an s from the inside of the nucleus to the periphery of the ucleusFigure 8
Careful examination of the series of sixteen individual optical sections along the Z axis reveals that LANA-1 induces a major 
rearrangement in the positioning of 3MK9H3 positive chromocenter remnants from the inside of the nucleus to the periphery 
of the nucleus. (LANA-1 – red, 3MK9H3 – green, DNA – blue).Page 10 of 16
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development of the numerous chromosome rearrange-
ments and translocations, seen in HHV8 carrying body
cavity lymphoma lines [21].
The analysis of deletion mutants has revealed an area, cor-
responding to the SUV39H1 binding site, is required for
the LANA-1 induced chromatin effects. SUV39H histone
methyltransferases govern histone H3 lysine 9 (H3–K9)
methylation at the pericentric heterochromatin and
induces a specialized histone methylation pattern that dif-
fers from the broad H3–K9 methylation present at other
chromosomal regions. Trimethyl H3K9 is a marker of
constitutive heterochromatin. Mouse chromocenters are
clusters of late-replicating pericentric heterochromatin
that contains heterochromatin associated protein 1 (HP1)
bound to 3M-H3K9. It has been suggested that H3–K9
methylation may function as a major "switch" for the
functional organization of chromosomal subdomains.
The viability of SUV39H-deficient mice is severely
impaired suggesting that the SUV39H HMTases are
important epigenetic regulators for mammalian develop-
ment [39]. The chromosomal instability of SUV39H-defi-
cient mice is associated with an increased tumor risk and
perturbed chromosome interactions during male meiosis.
Mouse cells, deficient for both SUV39H1 and H2 show
3D reconstitution of the triple-stained nuclei shows that LANA-1 staining and the 3MK9H3 positive remnants of the hetero-chromatic chromocent rs are non-overlappingFigure 9
3D reconstitution of the triple-stained nuclei shows that LANA-1 staining and the 3MK9H3 positive remnants of the hetero-
chromatic chromocenters are non-overlapping. See the full rotational image sequences in the supplementary material [see 
Additional file 1]. The selected middle sections (5–9) demonstrate the extensive peripheral localization of the chromocenters. 
High magnification representation of a single section shows mutual avoidance of 3MK9H3 staining and LANA-1 distribution. 
3D reconstitution of LANA-1 transfected nuclei also reveals well-defined nuclear areas that are devoid of LANA-1 staining. 
The identity and molecular content of these areas are currently unknown but they apparently include the nucleoli and the 
chromocentric remnants. The 3 dimensional digital cast of the LANA-1 negative areas in relation to 3mK9H3 and DNA stain-
ing is shown as image sequence in the supplementary material [see Additional file 2]. (LANA-1 – red, 3MK9H3 – green, DNA 
– blue).Page 11 of 16
(page number not for citation purposes)
Molecular Cancer 2007, 6:28 http://www.molecular-cancer.com/content/6/1/28very similar Hoechst 33258 staining patterns to the ones
that we have described in the present paper. Pericentro-
meric H3–K9 tri-methylation is believed to play an impor-
tant role in protecting genome stability. Our data suggest
that LANA-1 does not alter the overall level of H3–K9 tri-
methylation but releases DNA from heterochromatic
areas. Considering that the viral episomes are anchored to
the heterochromatin borderlines, the virus may need a
molecular mechanism to prevent overall heterochromati-
zation, as seen in the positional effect variegation
described in Drosophila and regulated by the fly variant of
SUV39 (Su(var)3–9 Suppressor of variegation 3–9).
LANA-1 may play a crucial role in the regulation of his-
tone modifications of the viral genes and those cellular
genes that are in close proximity to the viral episome.
Indeed, LANA-1 can mediate the inactivation of lytic cycle
associated genes in the neighborhood of the terminal
repeats through local interaction with SUV39H1. More
generally, LANA-1 may have a complex effect on the epi-
genetic modifications of the viral and host genome. It
interacts with a set of proteins that influence histone mod-
ifications responsible for heterochromatin formation. Its
interaction with retinoblastoma protein (RB1) may also
have a direct effect on heterochromatin formation.
Gonzalo et al. (2005) showed that members of the RB
family are directly involved of in heterochromatin forma-
tion, through their interaction with HMTs, independently
of the interaction with E2F. LANA-1 also binds to the de
novo DNA methyltransferases DNMT3A [40] that in turn
bind to another euchromatic histone methyltransferase
SETDB1/ESET. The latter can also trimethylate H3–K9
[41].
Unlike 3MK9H3, the heterochromatin associated methyl cytosine binding protein 2 (MECP2) shows an extensive release from the chromocenters of LANA-1 transfected L c lls bot  at m derate (left) and high expression levels (righ )Figure 10
Unlike 3MK9H3, the heterochromatin associated methyl cytosine binding protein 2 (MECP2) shows an extensive release from 
the chromocenters of LANA-1 transfected L cells both at moderate (left) and high expression levels (right). (LANA-1 – red, 
MECP2 – green, DNA – blue).Page 12 of 16
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Importantly however MECP2 is absent from the LANA bodies in BCBL-1 cells that harbor latent HHV-8 genomesFigu e 11
Importantly however MECP2 is absent from the LANA bodies in BCBL-1 cells that harbor latent HHV-8 genomes. (LANA-1 – 
red, MECP2 – green, DNA – blue).
Series of deletion mutants affecting both the C terminus and the central acidic repeats identify the N terminal area immediately preceding th  central cidic r peats as an area hat s required for the chromatin mod fyi g effectsFigure 12
Series of deletion mutants affecting both the C terminus and the central acidic repeats identify the N terminal area immediately 
preceding the central acidic repeats as an area that is required for the chromatin modifying effects. This area closely overlaps 
with the previously identified site of histone methyl transferase SUV39H1.
Molecular Cancer 2007, 6:28 http://www.molecular-cancer.com/content/6/1/28In the view of the massive effect of exogenously expressed
LANA-1 on chromatin structure in transfected cells it is
reasonable to assume that endogenous LANA in virus car-
rying cells has a similar effect on the neighboring chroma-
tin of LANA bodies that contain comparable quantities of
LANA in well circumscribed areas.
The focal concentration of LANA-1 in latently infected
cells with fixed anchorage to certain chromosomal sites
raises the possibility for an a new paradigm of the "epige-
netic modifier" that may generate locally altered chromatin
states in regions of the host genome, affected at random.
Once established it may be propagated over series of cell
divisions. The altered epigenetic state may affect target
genes involved in growth control. Through this mecha-
nism the anchored LANA bodies may directly participate
in the virus induced cellular transformation. This scenario
implies the experimentally testable prediction that the
altered expression of some cellular genes at the LANA
body anchorage sites may contribute to the generation of
HHV-8 harboring tumors such as Kaposi sarcomas and
body cavity lymphomas. Systematic cloning effort using
chromatin immunoprecipitation (Chip) material should
enrich for these sequences. To identify the important tar-
get sequences, individual clones from one anti-LANA
Chip cloning experiment should be arrayed. (Obviously
Deletion mutant (del 275–972) lacking the central acidic rep ats and he adjacent N terminal region show effective targ ting to surface of hetero hromatin b th in human MCF7 a d in mous  L-cells with ut any visible eff ct on the chrom ti organization r positi ning of chromoc ntersFigure 13
Deletion mutant (del 275–972) lacking the central acidic 
repeats and the adjacent N terminal region show effective 
targeting to the surface of heterochromatin both in human 
MCF7 and in mouse L-cells without any visible effect on the 
chromatin organization or positioning of chromocenters. 
(ΔLANA-1 – green, DNA – blue).
Chromatin dissolution effect is preserved in the deletion mutant LANA (ΔLANA-1 – green, DNA – blue)Figure 14
Chromatin dissolution effect is preserved in the deletion mutant LANA (ΔLANA-1 – green, DNA – blue). (del 332–972) as 
shown in four adjacent confocal sections of transfected L cell nuclei.Page 14 of 16
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Molecular Cancer 2007, 6:28 http://www.molecular-cancer.com/content/6/1/28clones with viral DNA inserts should be excluded). This
array should be repeatedly probed with labeled Chip
material from a number of HHV-8 bearing tumors from
different individuals (Chip-on-chip). Clones that consist-
ently light up with probes from a number of different
tumors may be good candidate targets for the "epigenetic
modifier" effect of the anchored viral episome.
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